Detalles de la búsqueda
1.
Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing.
Int J Mol Sci
; 24(14)2023 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511593
2.
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.
Cell Physiol Biochem
; 44(2): 594-606, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29161698
3.
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.
Breast Cancer Res
; 16(6): 485, 2014 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25432416
4.
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients.
Cells
; 13(9)2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727318
5.
Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact.
Cancers (Basel)
; 15(7)2023 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046635
6.
Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.
Cancers (Basel)
; 15(18)2023 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760481
7.
Emerging Role of YAP and the Hippo Pathway in Prostate Cancer.
Biomedicines
; 10(11)2022 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36359354
8.
Spatio-Temporal Variation of Lung Cancer in Crete, 1992-2013. Economic or Health Crisis?
Int J Environ Res Public Health
; 19(19)2022 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36231462
9.
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients.
Cancers (Basel)
; 15(1)2022 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612166
10.
Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives.
Cells
; 11(1)2021 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35011582
11.
Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane.
Cancer Chemother Pharmacol
; 87(2): 277-287, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515073
12.
Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer.
Cancers (Basel)
; 12(1)2020 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31963871
13.
Prostate Cancer: Quo Vadis?
Eur Urol
; 76(6): 709-711, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31300238
14.
CD8+ PD-1+ T-cells and PD-L1+ circulating tumor cells in chemotherapy-naïve non-small cell lung cancer: towards their clinical relevance?
Ther Adv Med Oncol
; 11: 1758835919853193, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217824
15.
A Deep Learning Framework for Predicting Response to Therapy in Cancer.
Cell Rep
; 29(11): 3367-3373.e4, 2019 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31825821
16.
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining.
Pharmacol Ther
; 203: 107395, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31374225
17.
Prognostic significance of CEACAM5mRNA-positive circulating tumor cells in patients with metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 82(5): 767-775, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30094617
18.
Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.
Ther Adv Med Oncol
; 10: 1758834017750121, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383038
19.
Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
Ann Gastroenterol
; 31(1): 65-70, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29333068
20.
MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer.
Mol Cancer Ther
; 17(7): 1430-1440, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703843